American Well Valuation
| AMWL Stock | USD 6.25 0.11 1.79% |
Above Model Estimate
Today
Current trading conditions suggest that American Well's price fluctuation is Elevated right now. Macroaxis calculates the intrinsic value estimate of American Well Corp using a 3 months time horizon. Negative margins (-40.0%) signal that the market sees earnings risk not yet reflected in the model's forward assumptions. Lengthening the time horizon typically improves pricing accuracy.
Value Estimates Divergence
The intrinsic value estimate for American Well is near $5.26 per share, compared with a market price of $6.25 - reading as above model estimate. The primary driver behind American Well's valuation is a profit margin of -40%, with a cross-check against technical indicators. As with most valuation work, the thesis depends on market price gradually reflecting the underlying business drivers.| Historical | Market 6.25 | Intrinsic 5.26 | Target 6.25 | Sentiment 6.17 | Naive 6.05 | DCF 4.48 |
The intrinsic value estimate of American Well stock captures the present value of expected future earnings and cash generation. The estimate depends on American Well's margin trajectory, reinvestment rate, and cost of capital. Approaches for estimating American Well's intrinsic value range from fundamental DCF models to relative benchmarks.
Both the upside potential and the downside risk of American Well Corp factor into a balanced assessment. The upside estimate depends on how quickly current margin or earnings headwinds resolve, while the downside reflects what happens if they persist. Evaluating where American Well's price sits within this range indicates whether the market leans toward the bull or bear case.
The most reliable valuation for American Well emerges when intrinsic-value models and market multiples point in the same direction. Some managers use American Well's intrinsic value based on ongoing forecasts of American Well's financial statements. The goal is to estimate American Well's intrinsic worth with reasonable confidence.
Main Profitability Drivers
The latest figures show American Well's net profit margin at -40.00% and operating margin at -44.00%. The positive spread between net and operating margins suggests American Well earns meaningful income outside its core operations. American Well generated 249.32 Million in revenue, producing 134.11 Million in gross profit (53.8% gross margin) and -95.7 Million in net income. Return on equity is -43.00% and return on assets is -31.00%, providing a view of how efficiently American Well's capital and asset base are deployed. Deteriorating profitability trends for American Well indicate that cost pressures or revenue weakness may be outpacing operational gains. A more granular view is available in American Well's profitability metrics for a broader perspective on earnings quality.
Price Book 0.4342 | Gross Profit | Price Sales 0.4176 | Profit Margin | Enterprise Value Revenue 0.7345 |
American Well Cash | 319.49 Million |
Cash stood at 182.33 Million as of December 31, 2025.
Revenue by Product
American Well's top line is composed of 3 product-level revenue streams. Platform Subscription leads at 28.84 Million, representing roughly 52.1% of the total, followed by Visits at 23.71 Million (42.9%). Revenue distribution shows a leading segment without excessive concentration, suggesting moderate product diversification.American Well is a medical equipment provider generating revenue through device sales, innovation, and healthcare demand, which directly shapes its valuation profile and margin structure. Classified as a turnaround stock in Health Care Equipment & Supplies, negative margins indicate the investment case rests on restoring operational profitability. The analysis below connects enterprise value. profitability, and capital structure to explain what the market is pricing today.
Total Value Analysis
The market-value snapshot for American Well Corp reflects enterprise value of -75.52 M, market capitalization of 104.12 M, debt of 4.52 M, and cash and equivalents of 581.61 M as of latest reporting. Reviewing American Well fundamentals is essential here — negative enterprise value can indicate either a deep value situation or a structural problem the market is pricing in.| Takeover Price | Market Cap | Debt Obligations | Cash & Equivalents |
-75.52 M | 104.12 M | 4.52 M | 581.61 M |
Investor Information
About 42.0% of AMWL shares are held by institutions such as insurance companies. AMWL has price-to-book (P/B) ratio of 0.43. Equities trading at this Price to Book (P/B) range may carry value potential, though margin and return quality should confirm. AMWL reported a loss per share of 5.96. AMWL had not issued any dividends in recent years. The firm completed a 0.050-for-1 stock split on 11th of July 2024. American Well Corp integrates capital discipline with pressured financial positioning. Asset returns have turned negative, signaling headwinds in the current operating cycle.Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. American Well has an asset utilization ratio of 77.0 percent. This suggests that the Company is making $0.77 for each dollar of assets. An increasing asset utilization means that American Well Corp is more efficient with each dollar of assets it utilizes for everyday operations.Macro event markers
Discounted Cash Flow Analysis
Using the current custom levered DCF inputs, American Well Corp is worth about 4.48 per share while the market is pricing it near 6.25. The market is pricing the shares around 28.3% over the model estimate. Current assumptions include 10.26% WACC, 2.0% perpetual growth, and about 849,254.94 of next-period free cash flow. Net debt is about -177.80 Million and the terminal value makes up roughly -6.0% of enterprise value.Model Value / Share
4.48
Equity value per share from the current custom levered DCF summary row.
Market Price
6.25
Current market price used by the same scenario.
Model Premium
28.3%
Market price sits above the model output.
WACC / LT Growth
10.26% / 2.0%
Forecast horizon: 2021 to 2030
American Market Price vs. Intrinsic Value
This chart compares observed market pricing with the model-derived equity value per share across forecast periods. It also illustrates the relative premium or discount, expressed as a percentage difference between market valuation and modeled intrinsic value.
Projected Revenue and Levered Free Cash Flow
Revenue and levered free cash flow projections are presented in billions, outlining the expected financial trajectory over the modeled horizon.
Key Model Assumptions
The inputs below reflect the core assumptions applied in the valuation model, including growth expectations, discount rates, and capital structure considerations.
| Input | Current Value |
|---|---|
| Weighted Average Cost of Capital | 10.26% |
| Long-Term Growth Rate | 2.0% |
| Cost of Equity | 10.54% |
| After-Tax Cost of Debt | 3.97% |
| Debt Weighting | 4.32% |
| Equity Weighting | 95.68% |
| Net Debt | -177.8 Million |
| Enterprise Value | -105.92 Million |
| Present Terminal Value | 6.31 Million |
| Terminal Value Share of EV | -6.0% |
Forecast Detail and Valuation Progression
This table presents the underlying forecast data used in the valuation, including revenue, cash flow generation, discounting effects, and the resulting per-share value across each projected period.
| Year | Revenue | Revenue Growth | Free Cash Flow | PV of LFCF | Equity Value / Share |
|---|---|---|---|---|---|
| 2021 | 252.79 Million | 0.00% | -142.1 Million | 0.0 | 4.48 |
| 2022 | 277.19 Million | 9.65% | -202.77 Million | 0.0 | 4.48 |
| 2023 | 259.05 Million | -6.55% | -163.59 Million | 0.0 | 4.48 |
| 2024 | 254.36 Million | -1.81% | -142.56 Million | 0.0 | 4.48 |
| 2025 | 249.32 Million | -1.98% | -65.97 Million | 0.0 | 4.48 |
| 2026 | 246.62 Million | -1.08% | -56.64 Million | -51.37 Million | 4.48 |
| 2027 | 245.16 Million | -0.59% | -40.84 Million | -33.6 Million | 4.48 |
| 2028 | 244.37 Million | -0.32% | -26.11 Million | -19.48 Million | 4.48 |
| 2029 | 243.94 Million | -0.18% | -12.25 Million | -8.29 Million | 4.48 |
| 2030 | 243.7 Million | -0.10% | 832,602.88 | 511,028.08 | 4.48 |
Profitability Analysis
An analysis of American Well's profitability data, American Well Corp is currently operating at a loss, with net income of -95.7 Million. The net profit margin is -40.0% and operating margin is -44.0%, with return on equity at -43.0%. Profitability is deteriorating broadly, with margin and return metrics declining across multiple levels of the income statement.Net Loss | First Reported 2019-03-31 | Previous Quarter -32.4 M | Current Value -24.9 M | Quarterly Volatility 71.1 M |
Macro event markers
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.47 | 0.5329 |
|
|
Profitability for American Well depends on margin structure, capital efficiency, and cost control. Both net and operating margins are negative (-40.0% and -44.0% respectively), indicating the business is consuming more capital than it generates at current revenue levels. The data below separates structural profitability from one-time items and cyclical effects. American Well reports return on equity of -43.0%, reflecting negative returns on shareholder capital.
Earnings per Share Projection vs Actual
The spread between high and low EPS estimates for American Well captures the degree of analyst disagreement on near-term earnings. The forward EPS estimate sits alongside trailing results as a dual lens on American Well's earnings trajectory. Tracking American Well's EPS alongside debt service and capital expenditure reveals underlying earnings durability. Consensus EPS estimates for American Well Corp represent the market's baseline earnings expectation. Deviations from this consensus on report day typically drive the sharpest price reactions. American Well reported estimated earnings of -0.77 in earnings per share on 31st of March 2026. The strongest signal comes from comparing this forecast against the company's historical beat/miss rate and recent guidance revisions.Macro event markers
Ownership Allocation
About 30% of American Well outstanding shares are owned by institutional investors. Institutional investors - such as mutual funds, pension funds, and asset managers - typically hold positions as part of a broader portfolio strategy, managing assets on behalf of clients. As a result, institutional investors are subject to reporting requirements and oversight rules - such as 13F filings - that differ from those for individual retail investors. Changes in institutional ownership of American Well can sometimes signal a shift in professional sentiment toward the company.Revenue and Profit Overview
AMWL reported previous year's revenue of 249.32 M. Net Loss for the year was -95.7 M with profit before overhead, payroll, taxes, and interest of 134.11 M.Interpreting Recent Signals
With margins currently negative, the business has not yet established consistent profitability, a dynamic that directly affects how sustainability of the current valuation is assessed. American Well carries minimal debt at 0.01, more financial cushion than many comparable companies - relevant during periods of heightened market volatility.
Valuation Synthesis
American Well Corp operates as a business currently operating below profitability breakeven within the Health Care Equipment & Supplies space. Negative margins are the dominant signal - the business is consuming more capital than it generates, which makes traditional valuation multiples unreliable as measures of intrinsic value. Until American Well can demonstrate sustained improvement in forward earnings expectations and sector dynamics, the market is likely to continue discounting the stock relative to peers with more established earnings power.
For American Well Corp, the valuation signals above are most useful when compared against future operating results as new data becomes available. With margins currently negative, the critical question is whether the path to profitability is supported by revenue trends and cost discipline.
Valuation Framework, Methodology & Assumptions
American Well is a micro-cap equity in Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care categories. Earnings quality influences long-term valuation stability. Current valuation multiples for American Well include P/S of 0.42.
Reported values for American Well Corp are derived from periodic company reporting and market reference feeds and standardized for analysis. Valuation outputs are model-derived and depend on published assumptions and reference inputs.
The analysis above is generated by quantitative models and is provided for informational and educational purposes only. It does not constitute financial advice, investment recommendations, or an endorsement to buy or sell any security. All investing involves risk, including the possible loss of principal. Consult a qualified financial advisor before making investment decisions. See our Terms of Use for full details.
Financial data referenced in this analysis is derived from publicly available SEC filings, audited financial statements, and third-party market data providers. The intrinsic value estimate is generated by Macroaxis quantitative models that incorporate fundamental analysis, technical indicators, and risk metrics.
The methodology combines multiple analytical inputs:
- Fundamental analysis - financial statements, profitability ratios, debt structure, and cash flow metrics sourced from SEC filings and public financial reports
- Technical indicators - historical price patterns, momentum signals, and volatility measures
- Risk assessment - probability of bankruptcy models, market risk metrics, and downside scenario analysis
- Peer comparison - relative valuation against industry peers using standardized multiples
Model outputs are refreshed periodically as new financial data becomes available. Past model performance is not indicative of future results. The intrinsic value estimate reflects a point-in-time calculation and should be considered alongside other research and professional advice.
Data sourced from SEC filings (EDGAR), public financial statements, and market data providers.
Editorial review and methodology oversight provided by: Vlad Skutelnik, Macroaxis Contributor
American Well Current Valuation Indicators
Valuation of American Well Corp is strongest when several lenses are used together: market cap, enterprise value. revenue, and cash-flow durability. Earnings multiples, cash-flow yields, and asset-based measures work best as a group rather than in isolation. Reported values are derived from company filings, audited financial statements, and market data, and are standardized within Macroaxis quantitative models for consistency. Model outputs reflect a point-in-time estimate based on available data and assumptions and should be interpreted alongside changes in operating performance, market conditions, and forward expectations.